SCHEMBL14733345

SCHEMBL14733345

Cc1ccc(N2CCN(c3ccc(Cl)cc3)S2(=O)=O)nc1N1CCN(C)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 8/20 0.42
HTR3A P46098 1/20 0.42
CNR1 P21554 2/20 0.41
KCNH2 Q12809 2/20 0.41
HTR1A P08908 1/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
MAT2A P31153 1/20 0.40
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 3/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ALOX12 P18054 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
HRH3 Q9Y5N1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14733343 0.88 KMT2A (0.44) HRH4HTR3AMAT2AKDM4EHSD17B10
SCHEMBL14733346 0.86 HRH4 (0.42) HRH4KDM4EHSD17B10MAPTNPC1
SCHEMBL2360158 0.85 HRH4 (0.44) HRH4HTR3AHTR1AMAT2AKDM4E
SCHEMBL14733340 0.81 DRD2 (0.43) HRH4HTR3ACNR1KCNH2HTR1A
SCHEMBL12445260 0.74 MAPT (0.45) HRH4HTR1AKDM4EMAPTNPC1
SCHEMBL2360090 0.73 CYP1A2 (0.43) HRH4HTR1ADRD2MAT2AHSD17B10
SCHEMBL14733341 0.68 KMT2A (0.47) HRH4HTR3AMAT2AHSD17B10MAPT
SCHEMBL14733339 0.68 HRH4 (0.45) HRH4KDM4EHSD17B10MAPTNPC1
SCHEMBL12444826 0.67 TSHR (0.39) HRH4HTR3AMAT2AMAPTKMT2A
SCHEMBL2333076 0.67 HRH4 (0.42) HRH4HTR3AHTR1ADRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053372-A1 5-HT RECEPTOR MODULATORS CAMBRIDGE ENTERPRISE LIMITED 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053372-A1 5-HT RECEPTOR MODULATORS HTR1B, HTR5A, HTR1A HRH4 350/4885HTR3A 11/4885CNR1 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.